Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Post by WarrantOfficeron Mar 04, 2021 8:54am
228 Views
Post# 32713275

Where from here?

Where from here?Great that we have 2 HC approvals. Where does this get us? Management must keep the momenteum moving forward. Do not want the stock to slide as this will jepordize any future financing. IMO, three key take aways from their website Voyageur Deck Nov 2020 

Voyageur and ThinQ in negotiations with Indian Contract Manufacturing Companies to begin immediate sales in the Indian market for iodine products - Sales targeted for 2021. When in 2021?

FDA applications for barium contrast will be filed with use of proceeds from financing: • Consultants in place. • FDA waiving fees on first product application - an update on FDA applications?

AVL Calgary facility to produce barium contrast, marketing and sales - renovations and upgrades were scheduled for completion the end of Jan 2021 and are supply lines pre-established?


<< Previous
Bullboard Posts
Next >>